investorscraft@gmail.com

Intrinsic ValueEssilorLuxottica S.A. (EI.SW)

Previous CloseCHF117.00
Intrinsic Value
Upside potential
Previous Close
CHF117.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

EssilorLuxottica SA operates as a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, serving diverse markets across North America, Europe, Latin America, Asia, Oceania, and Africa. The company’s vertically integrated model spans five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. Its Wholesale segment focuses on luxury and sports eyewear, while Retail drives direct-to-consumer sales. The Lenses and Optical Instruments segment is a technological powerhouse, offering advanced solutions like Varilux progressive lenses and Transitions photochromic lenses, alongside digital tools for opticians. EssilorLuxottica’s Equipment segment supports prescription labs with cutting-edge machinery, reinforcing its end-to-end industry dominance. The company’s market position is fortified by iconic brands such as Foster Grant, Ray-Ban, and Oakley, as well as strategic partnerships with Disney and Marvel. With 490 prescription laboratories worldwide, it combines scale with innovation, catering to both premium and mass-market segments. This dual focus on B2B and B2C channels, coupled with its R&D capabilities, positions EssilorLuxottica as a resilient player in the evolving eyewear industry, where demand for vision correction and fashion-driven accessories continues to grow.

Revenue Profitability And Efficiency

In FY 2023, EssilorLuxottica reported revenue of CHF 25.4 billion, with net income of CHF 2.29 billion, reflecting a net margin of approximately 9%. Operating cash flow stood at CHF 4.86 billion, underscoring robust cash generation. Capital expenditures of CHF 1.53 billion indicate sustained investment in production and technology, aligning with its vertically integrated strategy. The company’s operational efficiency is evident in its ability to maintain profitability while scaling globally.

Earnings Power And Capital Efficiency

Diluted EPS of CHF 5.08 highlights the company’s earnings strength, supported by its diversified revenue streams and cost management. The balance between high-margin luxury eyewear and volume-driven optical lenses optimizes capital allocation. EssilorLuxottica’s R&D focus on lens technology and digital tools further enhances its return on invested capital, reinforcing its competitive edge in innovation-driven markets.

Balance Sheet And Financial Health

EssilorLuxottica’s balance sheet remains solid, with CHF 2.56 billion in cash and equivalents against total debt of CHF 11.66 billion. The debt level is manageable given its strong cash flow generation and market position. The company’s liquidity and leverage ratios suggest financial flexibility to pursue growth initiatives or strategic acquisitions without compromising stability.

Growth Trends And Dividend Policy

The company has demonstrated consistent growth through organic expansion and acquisitions, particularly in emerging markets. A dividend of CHF 3.85 per share reflects a commitment to shareholder returns, supported by its cash flow resilience. Future growth may hinge on leveraging digital platforms and expanding its retail footprint in underpenetrated regions.

Valuation And Market Expectations

With a market capitalization of CHF 88.1 billion and a beta of 0.896, EssilorLuxottica is perceived as a stable investment with moderate volatility. The valuation reflects its industry leadership, though investor expectations may focus on margin expansion and the integration of recent acquisitions to drive future upside.

Strategic Advantages And Outlook

EssilorLuxottica’s strategic advantages lie in its brand portfolio, vertical integration, and global distribution network. The outlook remains positive, driven by increasing demand for vision care and premium eyewear. Challenges include macroeconomic headwinds and competitive pressures, but the company’s scale and innovation pipeline position it well for long-term growth.

Sources

Company annual report (FY 2023), Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount